
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.2B | -- | -- | $1.29 | -- |
08/04/2025 | Q2 | $1.1B | -- | -- | $1.04 | -- |
05/05/2025 | Q1 | $1B | $1B | $0.25 | $0.93 | -$0.68 |
02/24/2025 | Q4 | $1.1B | $1.2B | $0.78 | $1.14 | -$0.36 |
11/04/2024 | Q3 | $1.1B | $1.1B | $0.47 | $1.05 | -$0.58 |
08/06/2024 | Q2 | $1B | $1.1B | -$0.21 | $0.87 | -$1.08 |
05/07/2024 | Q1 | $972.5M | $1B | $0.04 | $0.81 | -$0.77 |
03/05/2024 | Q4 | $1B | $1B | -$0.02 | $1.05 | -$1.07 |
11/06/2023 | Q3 | $968.6M | $1B | -$0.21 | $0.86 | -$1.07 |
08/08/2023 | Q2 | $889.6M | $977.9M | $0.06 | $0.73 | -$0.67 |
05/09/2023 | Q1 | -- | $943.5M | -$0.57 | -- | -- |
03/02/2023 | Q4 | -- | $978.2M | -$0.47 | -- | -- |
11/08/2022 | Q3 | -- | $958.2M | -$0.57 | -- | -- |
08/09/2022 | Q2 | -- | $498.1M | $0.88 | -- | -- |
05/10/2022 | Q1 | -- | $456.5M | $0.24 | -- | -- |
12/31/2021 | Q4 | -- | $419.4M | $0.59 | -- | -- |
09/30/2021 | Q3 | -- | $459.4M | $0.87 | -- | -- |
06/30/2021 | Q2 | -- | $470.8M | $1.35 | -- | -- |
03/31/2021 | Q1 | -- | $434M | $1.02 | -- | -- |
12/31/2020 | Q4 | -- | $355.3M | $1.42 | -- | -- |
09/30/2020 | Q3 | -- | $352.4M | $0.88 | -- | -- |
06/30/2020 | Q2 | -- | $336.1M | $0.09 | -- | -- |
03/31/2020 | Q1 | -- | $351.7M | $0.74 | -- | -- |
12/31/2019 | Q4 | -- | $365.2M | $0.91 | -- | -- |
09/30/2019 | Q3 | -- | $359.9M | $0.67 | -- | -- |
06/30/2019 | Q2 | -- | $331.6M | $0.66 | -- | -- |
03/31/2019 | Q1 | -- | $325.9M | $0.62 | -- | -- |
12/31/2018 | Q4 | -- | $329.3M | $0.87 | -- | -- |
09/30/2018 | Q3 | -- | $308.1M | $0.86 | -- | -- |
06/30/2018 | Q2 | -- | $321.1M | $0.81 | -- | -- |
03/31/2018 | Q1 | -- | $320.5M | $0.54 | -- | -- |
12/31/2017 | Q4 | -- | $295.8M | $3.70 | -- | -- |
09/30/2017 | Q3 | -- | $269.6M | $0.51 | -- | -- |
06/30/2017 | Q2 | -- | $259.3M | $0.49 | -- | -- |
03/31/2017 | Q1 | -- | $290.1M | $0.60 | -- | -- |
12/31/2016 | Q4 | -- | $288.2M | $0.40 | -- | -- |
09/30/2016 | Q3 | -- | $283.8M | $0.60 | -- | -- |
06/30/2016 | Q2 | -- | $307.9M | $0.55 | -- | -- |
03/31/2016 | Q1 | -- | $310.7M | $0.61 | -- | -- |
12/31/2015 | Q4 | -- | $311.2M | $0.55 | -- | -- |
09/30/2015 | Q3 | -- | $299.1M | $1.29 | -- | -- |
V2X reported $1B worth of top line sales in its most recent quarter.
V2X announced earnings per share of $0.25 which represents a miss of analyst forecast a $0.93 per share.
V2X reported $78.1M that represents $2.44 per share over the last quarter.
V2X's earnings are forecast to grow from $1.08 per share to $4.17 per share next year representing an increase of 341.53%.
V2X's next earnings date is August 4, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.